Applications of synchrotron powder X-ray diffractometry in drug substance and drug product characterization

Bhushan Munjal, Raj Suryanarayanan

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

While X-ray powder diffractometry (XRD) is a powerful technique for characterizing crystalline phases, the sensitivity of the laboratory instruments can be a serious limitation. The use of synchrotron radiation has substantially enhanced its utility and synchrotron XRD (SXRD) has emerged as a powerful tool for analyzing pharmaceutical materials. The numerous applications of SXRD in both drug substance and drug product characterization have been comprehensively summarized. The applications are categorized into three areas: 1) Detection, characterization and quantification of multiple physical forms of the API in the DS. 2) Similar investigations in complex and multicomponent drug products. 3) Characterization and quantification of phase transformations during processing and storage. Thus, SXRD based studies have assisted pharmaceutical development by enhancing the understanding of mechanisms and kinetics of phase transformations during various pharmaceutical unit operations including crystallization and freeze drying. Subtle and nuanced information has been obtained during DP dissolution and long-term stability studies.

Original languageEnglish (US)
Article number116181
JournalTrAC - Trends in Analytical Chemistry
Volume136
DOIs
StatePublished - Mar 1 2021

Bibliographical note

Funding Information:
The work was partially supported by the William and Mildred Peters Endowment Fund.

Publisher Copyright:
© 2021 Elsevier B.V.

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Keywords

  • Crystallinity
  • Drug product
  • Drug substance
  • Phase transformations
  • Physical characterization
  • Polymorphism
  • Solid state
  • Synchrotron powder X-ray diffraction

Fingerprint

Dive into the research topics of 'Applications of synchrotron powder X-ray diffractometry in drug substance and drug product characterization'. Together they form a unique fingerprint.

Cite this